Ausgabe 3/2017
Inhalt (30 Artikel)
Polymorphisms of the TGF-β1 gene and the risk of acquired aplastic anemia in a Chinese population
Xue-hong Liang, Liucheng Rong, Guangsheng He, Hailong He, Shengyun Lin, Yan Yang, Yao Xue, Yongjun Fang
GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling
Corinna Koch, Bardia Samareh, Tatsuya Morishima, Perihan Mir, Lothar Kanz, Cornelia Zeidler, Julia Skokowa, Karl Welte
Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012
Luiz Claudio Santos Thuler, Maria S. Pombo-de-Oliveira
Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?
Etienne Paubelle, Sophie Ducastelle-Leprêtre, Hélène Labussière-Wallet, Franck Emmanuel Nicolini, Fiorenza Barraco, Adriana Plesa, Gilles Salles, Eric Wattel, Xavier Thomas
Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004–2013
Ja Min Byun, Young Jin Kim, Taemi Youk, John Jeongseok Yang, Jongha Yoo, Tae Sung Park
JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort
Jean-Christophe Ianotto, Aurélie Chauveau, Dominique Mottier, Valérie Ugo, Christian Berthou, Eric Lippert, Aurélien Delluc
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN
Massimo Breccia, Alessandro Andriani, Marco Montanaro, Elisabetta Abruzzese, Francesco Buccisano, Michele Cedrone, Antonietta Centra, Nicoletta Villivà, Francesca Celesti, Malgorzata Monica Trawinska, Fulvio Massaro, Ambra Di Veroli, Barbara Anaclerico, Gioia Colafigli, Matteo Molica, Antonio Spadea, Luca Petriccione, Giuseppe Cimino, Roberto Latagliata
Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations
Danijela Lekovic, Mirjana Gotic, Radek Skoda, Bojana Beleslin-Cokic, Natasa Milic, Olivera Mitrovic-Ajtic, Ronny Nienhold, Dijana Sefer, Tijana Suboticki, Marijana Buac, Dragana Markovic, Milos Diklic, Vladan P. Cokic
Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Ivan Dlouhy, Miguel Á. Torrente, Sabela Lens, Jordina Rovira, Laura Magnano, Eva Giné, Julio Delgado, Olga Balagué, Antonio Martínez, Elías Campo, Xavier Forns, José M. Sánchez-Tapias, Armando López-Guillermo
Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment
Hideaki Kitahara, Dai Maruyama, Akiko Miyagi Maeshima, Shinichi Makita, Ken-ichi Miyamoto, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Yukio Kobayashi, Kinuko Tajima, Takashi Terauchi, Hiroaki Kurihara, Hirokazu Taniguchi, Norio Komatsu, Kensei Tobinai
BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients
Stefanie Gilli, Urban Novak, Behrouz Mansouri Taleghani, Gabriela M. Baerlocher, Kurt Leibundgut, Yara Banz, Thilo Zander, Daniel Betticher, Thomas Egger, Daniel Rauch, Thomas Pabst
Bortezomib-containing regimens (BCR) for the treatment of non-transplant eligible multiple myeloma
Victor H Jimenez-Zepeda, Peter Duggan, Paola Neri, Jason Tay, Nizar J Bahlis
Improved clinical outcomes for multiple myeloma patients treated at a single specialty clinic
Ariana Berenson, Suzie Vardanyan, Michael David, James Wang, Nika Manik Harutyunyan, Jillian Gottlieb, Ran Halleluyan, Tanya M. Spektor, Kyle A. Udd, Shahrooz Eshaghian, Youram Nassir, Benjamin Eades, Regina Swift, James R. Berenson
Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
Ariana Berenson, Suzie Vardanyan, Michael David, James Wang, Nika Manik Harutyunyan, Jillian Gottlieb, Ran Halleluyan, Tanya M. Spektor, Kyle A. Udd, Shahrooz Eshaghian, Youram Nassir, Benjamin Eades, Regina Swift, James R. Berenson
Comparison of engraftment following different stem cell mobilization modalities in patients with multiple myeloma treated with a uniform induction regimen containing bortezomib, cyclophosphamide and dexamethasone
Noam Benyamini, Irit Avivi, Eldad J. Dann, Tsila Zuckerman, Noa Lavi, Tami Katz
Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8
Takaaki Konuma, Tadakazu Kondo, Takuya Yamashita, Naoyuki Uchida, Takahiro Fukuda, Yukiyasu Ozawa, Kazuteru Ohashi, Hiroyasu Ogawa, Chiaki Kato, Satoshi Takahashi, Heiwa Kanamori, Tetsuya Eto, Chiaki Nakaseko, Akio Kohno, Tatsuo Ichinohe, Yoshiko Atsuta, Akiyoshi Takami, Shingo Yano
Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML
Udo Holtick, Marco Herling, Natali Pflug, Geothy Chakupurakal, Silke Leitzke, Dominik Wolf, Michael Hallek, Christof Scheid, Jens M. Chemnitz
Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause
Johanna Gebhart, Sylvia Kepa, Stefanie Hofer, Silvia Koder, Alexandra Kaider, Alisa S. Wolberg, Helmuth Haslacher, Peter Quehenberger, Ernst Eigenbauer, Simon Panzer, Christine Mannhalter, Ingrid Pabinger
Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome
Fatemeh Behnia, Saeed Elojeimy, Manuela Matesan, David C. Fajgenbaum
Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
Zimu Gong, Lan Zheng, Zhenya Tang, Zi Chen, Wei Wang, Shi Bai, Guilin Tang, L. Jeffrey Medeiros, Shimin Hu
Evidence for a role of decitabine in the treatment of myeloid sarcoma
Max Gornicec, Albert Wölfler, Susanne Stanzel, Heinz Sill, Armin Zebisch
Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center
Karla Javier González, Sebastian Ortiz Zuluaga, Carolina Villegas DaRos, Pedro Pérez Rodríguez, Antonio Cerveró Martí
Cold agglutinin disease complicated by acrocyanosis and necrosis
Gareth P. Gregory, Ann Farrell, Susan Brown
Cyclin A2 as a potential differential marker of splenic diffuse red pulp small B-cell lymphoma: a report of the first case
Khaoula Ben Younes, Raoudha Doghri, Karima Mrad, Neila Ben Romdhane, Fatma Ben Aissa-Fennira
Radiologic and molecular remission of follicular T cell lymphoma treated with lenalidomide
Yok-Lam Kwong
Intravascular lymphoma: look through the small vessels
Concepción Prats-Martín, Emilio Franco-Macías, Rosario M. Morales-Camacho, Olga Pérez, M. Teresa Vargas, Fátima de la Cruz Vicente, Juan J. Borrero, Ricardo Bernal, José A. Pérez-Simón
Presence of risk factors does not affect outcome in early stage pediatric Hodgkin lymphoma treated with ABVD
Sainath Bhethanabhotla, Sameer Bakhshi
Late isolated intraocular relapse of a systemic diffuse large B-cell lymphoma detected by flow cytometry
Edurne Sarrate, Marc Sorigue, Miriam Carbajal, Inmaculada Portal, Juan-Manuel Sancho, Jordi Juncà
Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence
Shin Yeu Ong, Yun Ann Chin, Hein Than, Chuen Wen Tan, Eng Soo Yap, Wan Hui Wong, Heng Joo Ng
Reversion of serum VZV-IgG antibody preceding disseminated visceral varicella zoster after hematopoietic stem cell transplantation
Sayaka Arakawa, Hidenori Kage, Haruka Chino, Munetoshi Hinata, Akimasa Hayashi, Takashi Toya, Satoshi Noguchi, Tetsuo Ushiku, Yasuhiro Yamauchi, Mineo Kurokawa, Masashi Fukayama, Takahide Nagase